Completed PHASE4 INTERVENTIONAL NCT00373126

The Effects of Nicotine Withdrawal on Reward Responsivity in Schizophrenia

A Double-Blind, Placebo-Controlled Trial of Reward Responsivity During Nicotine Withdrawal in Smokers With Schizophrenia and Normal Controls

Sponsor: Massachusetts General Hospital

Conditions Schizoaffective Disorder Schizophrenia

Interventions transdermal nicotine patch

Updated 5 times since 2017 Last updated: May 14, 2009 Started: Apr 30, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Schizoaffective Disorder and Schizophrenia, this trial is completed. The trial is conducted by Massachusetts General Hospital and has accumulated 5 data snapshots since 2005. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Apr 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Massachusetts General Hospital
North Suffolk Mental Health Association

Data source: North Suffolk Mental Health Association

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boston, United States